X0607 3 2026-10-13 0 0001833141 Helus Pharma Inc. HELP 0002159392 Inamdar Amir true C/O HELUS PHARMA INC. 100 KING STREET WEST, SUITE 5600 TORONTO A6 M5X 1C9 ONTARIO, CANADA true false false false Common Shares 224332 I Held by Zephyr Life Sciences Ltd. Common Shares 3490 D Restricted Share Units Common Shares 66668 I Held by Zephyr Life Sciences Inc. Held by Zephyr Life Sciences Ltd., a United Kingdom corporation owned and controlled by the reporting person. On October 1, 2025, the Reporting Person was granted 100,000 restricted share units ("RSUs") which vest as follows: 8,333 RSUs vesting on January 6, 2026, and 8,333 RSUs vesting quarterly over three years on November 20, February 20, May 20, and August 20 until fully vested. As of the date of this Form 3, the Reporting Person holds 66,668 unvested RSUs from the October 2025 grant. Each RSU represents a right to receive one Issuer common share. /s/ Amir Inamdar 2026-10-26